The Gut Microbiome Correlated to Chemotherapy Efficacy in Diffuse Large B-Cell Lymphoma Patients

被引：5

作者：

Xu, Zhuo-Fan ^{[1
,2
]}

Yuan, Li ^{[1
]}

Zhang, Yan ^{[1
]}

Zhang, Wei ^{[1
]}

Wei, Chong ^{[1
]}

Wang, Wei ^{[1
]}

Zhao, Danqing ^{[1
]}

Zhou, Daobin ^{[1
,3
]}

Li, Jingnan ^{[4
]}

机构：

[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Hematol, Beijing 100005, Peoples R China

[2] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, State Key Lab Complex Severe & Rare Dis, Beijing 100005, Peoples R China

[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gastroenterol, Beijing 100005, Peoples R China

来源：

HEMATOLOGY REPORTS | 2024年 / 16卷 / 01期

基金：

中国国家自然科学基金;

关键词：

diffuse large B-cell lymphoma; gut microbiota; 16S rRNA; metagenomic sequencing; Proteobacteria; BACTERIA; STRESS; GENE;

D O I：

10.3390/hematolrep16010007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The gut microbiome (GMB) has been extensively reported to be associated with the development and prognosis of human diseases. This study aims to investigate the relationship between GMB composition and chemotherapy efficacy in diffuse large B-cell lymphoma (DLBCL). We demonstrated that DLBCL patients at diagnosis have altered GMB compositions. Significant enrichment of the Proteobacteria phylum in DLBCL patients was observed. Gene analysis showed a high abundance of virulence factors genes. We found baseline GMB to be associated with clinical outcomes. The emergence of Lactobacillus fermentum was correlated with better treatment outcome. Our pilot results suggested a correlation between GMB composition and DLBCL development and prognosis. Clues from our study, together with previous research, provided a rational foundation for further investigation on the pathogenesis, prognosis value, and targeted therapy of GMB in DLBCL.

引用

页码：63 / 75

页数：13

共 50 条

[21] Diffuse Large B-Cell Lymphoma
Lang, Raynell
Gill, M. John
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2261 - 2262
[22] Diffuse Large B-Cell Lymphoma
Friedberg, Jonathan W.
Fisher, Richard I.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 941 - +
[23] Diffuse large B-cell lymphoma
Shahi, Parham Khosravi
Manga, Gumersindo Perez
MEDICINA CLINICA, 2006, 127 (01): : 17 - 21
[24] Diffuse large B-cell lymphoma
Alcantara, Marion
Huynh, Tony
HEMATOLOGIE, 2016, 22 (02): : 159 - 166
[25] Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma
Agustin Avilés
M. Jesús Nambo
Natividad Neri
Alejandra Talavera
Claudia Castañeda
Edgar Murillo
Sergio Cleto
Judith Huerta-Guzmán
Medical Oncology, 2004, 21 : 269 - 272
[26] Topo IIa gene alterations correlated with survival in patients with diffuse large B-cell lymphoma
Chen, Zhenwen
Wang, Jinfen
Zhang, Hongwei
Liu, Dongmei
Li, Yi
Xu, Yirong
Tan, Dongfeng
Chen, Dong
Zhao, Xia
Wang, Guoping
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (03) : 310 - 320
[27] Diffuse large B-cell lymphoma and return to work: influence of chemotherapy
Basso, M.
Herin, F.
Rueter, M.
Despas, F.
Laurent, G.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 45 - 45
[28] Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
Hu, Xin
Zeng, Min
Yang, Shun-e
Liang, Xiao
Ding, Shan-shan
Guo, Li
Li, Shan
Wen, Shu-juan
MEDICINE, 2017, 96 (45)
[29] Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study
Jiang Xiao
Shuxu Du
Guorui Dai
Guiju Gao
Di Yang
Hongxin Zhao
Scientific Reports, 7
[30] Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study
Xiao, Jiang
Du, Shuxu
Dai, Guorui
Gao, Guiju
Yang, Di
Zhao, Hongxin
SCIENTIFIC REPORTS, 2017, 7

← 1 2 3 4 5 →